Genetic Diagnostic Yield in Autism Spectrum Disorder (ASD) and Epilepsy Phenotypes in Children with Genetically Defined ASD.
Saved in:
| Title: | Genetic Diagnostic Yield in Autism Spectrum Disorder (ASD) and Epilepsy Phenotypes in Children with Genetically Defined ASD. |
|---|---|
| Authors: | Lob, Karen (AUTHOR), Sawka, Danielle M. (AUTHOR), Gaitanis, John N. (AUTHOR), Liu, Judy S. (AUTHOR), Nie, Duyu A. (AUTHOR) |
| Source: | Journal of Autism & Developmental Disorders. Dec2025, Vol. 55 Issue 12, p4324-4336. 13p. |
| Subjects: | Genetics of epilepsy, Genetics of autism, Age of onset, Data analysis, Research funding, Fisher exact test, Retrospective studies, Age distribution, Magnetic resonance imaging, Mann Whitney U Test, Chi-squared test, Descriptive statistics, Developmental disabilities, Odds ratio, Epilepsy, Medical records, Acquisition of data, Statistics, Asperger's syndrome, Data analysis software, Confidence intervals, Phenotypes, Genetic testing, Genotypes, Sequence analysis, Drug resistance, Comorbidity |
| Abstract: | We compared the epilepsy phenotypes in children with genetically defined versus undefined autism spectrum disorder (ASD). A single-center retrospective study was conducted to investigate diagnostic yields of different genetic testing for children with ASD. Patients with at least one testing modality were included and classified as having genetically defined ASD or not based on updated genotype–phenotype correlation. Of the 523 patients included, 79 (15.1%) had results explaining their ASD diagnosis. WES (whole exome sequencing) outperformed CMA (chromosomal microarray) on diagnostic yield (23.0% versus 8.3%). Compared to those with non-diagnostic test(s), children with genetically defined ASD were associated with higher rates for microcephaly, hypotonia, dysmorphic features, and developmental delay/regression. The prevalence of epilepsy was significantly higher in children with genetically defined ASD than those without a genetic diagnosis (35.4% versus 16.4%, p < 0.001, power = 0.97). Furthermore, children with genetically defined ASD had a younger age of epilepsy onset (median 2.2 versus 5.0 years, p = 0.002, power = 0.90) and a higher rate of drug-resistant epilepsy although not reaching statistical significance (35.7% versus 21.9%, p = 0.20). Our study has provided further evidence to support WES as first-tier test for children with ASD and that an early genetic diagnosis has the potential to inform further surveillance and management for ASD comorbid conditions including epilepsy. [ABSTRACT FROM AUTHOR] |
| Copyright of Journal of Autism & Developmental Disorders is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: pbh DbLabel: Psychology and Behavioral Sciences Collection An: 189168304 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Genetic Diagnostic Yield in Autism Spectrum Disorder (ASD) and Epilepsy Phenotypes in Children with Genetically Defined ASD. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Lob%2C+Karen%22">Lob, Karen</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sawka%2C+Danielle+M%2E%22">Sawka, Danielle M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gaitanis%2C+John+N%2E%22">Gaitanis, John N.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Judy+S%2E%22">Liu, Judy S.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nie%2C+Duyu+A%2E%22">Nie, Duyu A.</searchLink> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Journal+of+Autism+%26+Developmental+Disorders%22">Journal of Autism & Developmental Disorders</searchLink>. Dec2025, Vol. 55 Issue 12, p4324-4336. 13p. – Name: Subject Label: Subjects Group: Su Data: <searchLink fieldCode="DE" term="%22Genetics+of+epilepsy%22">Genetics of epilepsy</searchLink><br /><searchLink fieldCode="DE" term="%22Genetics+of+autism%22">Genetics of autism</searchLink><br /><searchLink fieldCode="DE" term="%22Age+of+onset%22">Age of onset</searchLink><br /><searchLink fieldCode="DE" term="%22Data+analysis%22">Data analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Research+funding%22">Research funding</searchLink><br /><searchLink fieldCode="DE" term="%22Fisher+exact+test%22">Fisher exact test</searchLink><br /><searchLink fieldCode="DE" term="%22Retrospective+studies%22">Retrospective studies</searchLink><br /><searchLink fieldCode="DE" term="%22Age+distribution%22">Age distribution</searchLink><br /><searchLink fieldCode="DE" term="%22Magnetic+resonance+imaging%22">Magnetic resonance imaging</searchLink><br /><searchLink fieldCode="DE" term="%22Mann+Whitney+U+Test%22">Mann Whitney U Test</searchLink><br /><searchLink fieldCode="DE" term="%22Chi-squared+test%22">Chi-squared test</searchLink><br /><searchLink fieldCode="DE" term="%22Descriptive+statistics%22">Descriptive statistics</searchLink><br /><searchLink fieldCode="DE" term="%22Developmental+disabilities%22">Developmental disabilities</searchLink><br /><searchLink fieldCode="DE" term="%22Odds+ratio%22">Odds ratio</searchLink><br /><searchLink fieldCode="DE" term="%22Epilepsy%22">Epilepsy</searchLink><br /><searchLink fieldCode="DE" term="%22Medical+records%22">Medical records</searchLink><br /><searchLink fieldCode="DE" term="%22Acquisition+of+data%22">Acquisition of data</searchLink><br /><searchLink fieldCode="DE" term="%22Statistics%22">Statistics</searchLink><br /><searchLink fieldCode="DE" term="%22Asperger's+syndrome%22">Asperger's syndrome</searchLink><br /><searchLink fieldCode="DE" term="%22Data+analysis+software%22">Data analysis software</searchLink><br /><searchLink fieldCode="DE" term="%22Confidence+intervals%22">Confidence intervals</searchLink><br /><searchLink fieldCode="DE" term="%22Phenotypes%22">Phenotypes</searchLink><br /><searchLink fieldCode="DE" term="%22Genetic+testing%22">Genetic testing</searchLink><br /><searchLink fieldCode="DE" term="%22Genotypes%22">Genotypes</searchLink><br /><searchLink fieldCode="DE" term="%22Sequence+analysis%22">Sequence analysis</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+resistance%22">Drug resistance</searchLink><br /><searchLink fieldCode="DE" term="%22Comorbidity%22">Comorbidity</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: We compared the epilepsy phenotypes in children with genetically defined versus undefined autism spectrum disorder (ASD). A single-center retrospective study was conducted to investigate diagnostic yields of different genetic testing for children with ASD. Patients with at least one testing modality were included and classified as having genetically defined ASD or not based on updated genotype–phenotype correlation. Of the 523 patients included, 79 (15.1%) had results explaining their ASD diagnosis. WES (whole exome sequencing) outperformed CMA (chromosomal microarray) on diagnostic yield (23.0% versus 8.3%). Compared to those with non-diagnostic test(s), children with genetically defined ASD were associated with higher rates for microcephaly, hypotonia, dysmorphic features, and developmental delay/regression. The prevalence of epilepsy was significantly higher in children with genetically defined ASD than those without a genetic diagnosis (35.4% versus 16.4%, p < 0.001, power = 0.97). Furthermore, children with genetically defined ASD had a younger age of epilepsy onset (median 2.2 versus 5.0 years, p = 0.002, power = 0.90) and a higher rate of drug-resistant epilepsy although not reaching statistical significance (35.7% versus 21.9%, p = 0.20). Our study has provided further evidence to support WES as first-tier test for children with ASD and that an early genetic diagnosis has the potential to inform further surveillance and management for ASD comorbid conditions including epilepsy. [ABSTRACT FROM AUTHOR] – Name: AbstractSuppliedCopyright Label: Group: Ab Data: <i>Copyright of Journal of Autism & Developmental Disorders is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=189168304 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s10803-024-06512-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 4324 Subjects: – SubjectFull: Genetics of epilepsy Type: general – SubjectFull: Genetics of autism Type: general – SubjectFull: Age of onset Type: general – SubjectFull: Data analysis Type: general – SubjectFull: Research funding Type: general – SubjectFull: Fisher exact test Type: general – SubjectFull: Retrospective studies Type: general – SubjectFull: Age distribution Type: general – SubjectFull: Magnetic resonance imaging Type: general – SubjectFull: Mann Whitney U Test Type: general – SubjectFull: Chi-squared test Type: general – SubjectFull: Descriptive statistics Type: general – SubjectFull: Developmental disabilities Type: general – SubjectFull: Odds ratio Type: general – SubjectFull: Epilepsy Type: general – SubjectFull: Medical records Type: general – SubjectFull: Acquisition of data Type: general – SubjectFull: Statistics Type: general – SubjectFull: Asperger's syndrome Type: general – SubjectFull: Data analysis software Type: general – SubjectFull: Confidence intervals Type: general – SubjectFull: Phenotypes Type: general – SubjectFull: Genetic testing Type: general – SubjectFull: Genotypes Type: general – SubjectFull: Sequence analysis Type: general – SubjectFull: Drug resistance Type: general – SubjectFull: Comorbidity Type: general Titles: – TitleFull: Genetic Diagnostic Yield in Autism Spectrum Disorder (ASD) and Epilepsy Phenotypes in Children with Genetically Defined ASD. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lob, Karen – PersonEntity: Name: NameFull: Sawka, Danielle M. – PersonEntity: Name: NameFull: Gaitanis, John N. – PersonEntity: Name: NameFull: Liu, Judy S. – PersonEntity: Name: NameFull: Nie, Duyu A. IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: Dec2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 01623257 Numbering: – Type: volume Value: 55 – Type: issue Value: 12 Titles: – TitleFull: Journal of Autism & Developmental Disorders Type: main |
| ResultId | 1 |